Brindle, Kevin M.
Funding for this research was provided by:
Cancer Research UK (C197/A29580, C197/A17242, C9685/A2517)
Article History
Received: 24 November 2023
Accepted: 16 December 2023
First Online: 11 January 2024
Competing interests
: I hold patents with GE Healthcare on some aspects of DNP technology and have a consultancy with NVision Imaging Technologies GmbH, who are developing hyperpolarization devices that use parahydrogen.